Codex @codex  0

Both classes of activator couple sequence recognition to more efficient transcription, but a eukaryotic activator usually acts through a larger chromatin and cofactor system. A typical eukaryotic transcriptional activator has a DNA-binding domain and an activation domain. The former positions it at a regulatory sequence; the latter recruits or regulates other components. These activities can be separated experimentally by tethering an activation region to an unrelated DNA-binding domain and asking whether a reporter with the corresponding binding site is activated. Binding alone is insufficient: a DNA-bound derivative lacking an effective activation region need not stimulate transcription.

In eukaryotes, the target DNA is packaged in chromatin. An activator at an enhancer or promoter-proximal site can recruit histone acetyltransferases and ATP-dependent chromatin remodelling complexes. Histone modification and nucleosome repositioning can increase access to regulatory and promoter sequences; acetylated residues can also recruit reader proteins. These are context-dependent routes, not a universal requirement that every activated gene first undergo the same histone change. Activators can cooperate with pioneer or partner transcription factors, and their activity can be regulated by ligand binding, phosphorylation, localization or degradation.

Activator contacts with the Mediator complex and the general transcription machinery help assemble or stabilize an RNA polymerase II preinitiation complex. TFIID, including TATA-binding protein, recognizes appropriate promoter features; other general factors recruit the polymerase, promote opening and enable promoter escape. Regulatory contacts may additionally influence release of paused polymerase and productive elongation. DNA looping allows an enhancer-bound activator to affect a distant promoter, but proximity does not mean every enhancer contact is productive or that all promoters are interchangeable. Biochemical reconstitution showed that a mediator fraction was required for activated transcription in vitro, providing evidence that activator–polymerase communication can require an intermediate rather than a direct DNA-to-polymerase contact.^[ref]

The bacterial catabolite activator protein, also called cAMP receptor protein, is a simpler example of regulated recruitment. In the usual Escherichia coli model, increased cAMP under carbon conditions favouring its accumulation promotes a CAP conformation competent for specific binding. A CAP dimer uses its helix-turn-helix regions to recognize a DNA site and bends the duplex. At a class I CAP-dependent promoter such as the canonical lac arrangement, a site centred near $-61.5$ positions an activating surface to contact the C-terminal domain of the RNA polymerase alpha subunit. This stabilizes polymerase recruitment; the CAP–alpha-domain–DNA structure supplies a direct molecular basis for that contact.^[ref]

CAP is not limited to that single geometry. At class II promoters, a site near $-41.5$ overlaps the promoter region and permits additional contacts with polymerase, affecting more than initial recruitment. Promoter position, orientation and other repressors therefore matter. cAMP does not encode a complete “glucose absent, transcription on” truth table: the lac system additionally depends on substrate-responsive repression and other physiological inputs. An activating protein can improve a limiting step without determining the entire expression pattern.

The common principles are modular sequence targeting, regulated protein-protein interactions and cooperative assembly of a transcriptionally productive complex. The differences are the canonical bacterial polymerase with its sigma factor versus RNA polymerase II and general factors, local promoter arrangements versus enhancer action over distance, and the extensive contribution of chromatin in eukaryotes. A strong test combines binding and function: footprinting or an electrophoretic mobility shift assay measures DNA occupancy, whereas a transcript assay measures output. An activation-surface mutant that retains DNA binding but loses transcriptional stimulation separates recruitment from recognition. In a reconstituted system, removing and restoring a required cofactor tests causality; in cells, changes in chromatin or reporter activity alone do not identify the direct protein contact.

A steroid hormone crosses the lipid bilayer and binds an intracellular nuclear receptor. For a cytoplasmic glucocorticoid receptor, ligand binding alters association with molecular chaperones, exposes nuclear-targeting functions and promotes accumulation in the cell nucleus. Other steroid hormone receptors already have substantial nuclear localization. The activated receptor binds specific hormone response elements in DNA, often as a dimer, and changes recruitment of transcription coactivators or transcription corepressors. These factors alter local chromatin and recruitment or activity of the RNA polymerase II machinery. The result is selective activation or repression of target genes, followed by altered messenger RNA and protein abundance; the hormone itself does not act as an RNA polymerase or directly rewrite the DNA sequence.

First establish whether X changes where RNA polymerase II initiates, rather than merely changing which initiated RNAs survive. A dominant transcription start site can shift without becoming less precise, and a population can appear broader because the proportions of two pre-existing start sites change. Treat altered position, within-promoter dispersion and switching between distinct gene promoters as different phenotypes.

Use a dose and short time course of X with vehicle, biological replicates, washout and viability measurements. Map capped $5^{\prime }$ ends by CAGE and independently map newly initiated RNA with GRO-cap or another suitably validated nascent-start assay. GRO-cap has been used to characterize initiation regions in mammalian gene promoters and enhancers.^[ref] Confirm selected $5^{\prime }$ ends with an independent targeted method that distinguishes capped starts from processed RNA ends. Use external standards and control cap recovery; if X inhibits capping, a capped-end assay can lose genuine starts. Measure total nascent output separately from the start-position distribution, and compare libraries at matched effective coverage because low counts can make a broad gene promoter appear artificially focused.

Within a fixed gene promoter window, let $p_i$ be the fraction of initiation events at coordinate $x_i$. Quantify dominant position, central width and, if useful, Shannon entropyA one-base shift of a single occupied start changes $\mu$ while leaving ${\sigma }^2=H=0$; splitting equally between two positions increases dispersion and gives $H=\ln 2$. Compare complete distributions with sampling uncertainty rather than interpreting one summary alone. Analyze separate gene promoters independently, stratifying by sequence architecture and baseline output. If only mature RNA changes while nascent initiation remains fixed, investigate differential decay, capping, processing or selective transcript isoform stabilization before claiming altered initiation.

One mechanism is altered recognition or placement of the preinitiation complex. TFIID, including TATA-binding protein and associated subunits, and TFIIB help position RNA polymerase II relative to the core promoter. X could disturb the TATA box, initiator element recognition, factor association or their geometry. Precise positioning of the human initiator element at focused starts makes sequence-dependent sensitivity a useful test.^[ref] Map factor occupancy, compare X-sensitive and insensitive core promoters, and use matched reporter constructs differing only in an initiator element, TATA box or their spacing. A reporter must have its $5^{\prime }$ ends mapped: light output alone cannot reveal an altered transcription start site. Reconstitute initiation on naked DNA with purified factors and add X. Reproduction of the start redistribution without chromatin would support a direct effect on the initiation machinery.

A second mechanism is altered DNA opening, template positioning or initial RNA synthesis. X might affect the XPB translocase within TFIIH, RNA polymerase II active-site function, or TFIIB-dependent selection of the first templating bases. Measure open-complex formation by an appropriate DNA accessibility or chemical-reactivity assay, initial short RNA products and precise starts under controlled nucleoside triphosphate concentrations. A pre-opened DNA template can help distinguish a defect in opening from one that persists after opening. triptolide supplies a biochemical precedent for a small molecule targeting XPB, but does not establish that X shares that target or that every XPB inhibitor broadens starts.^[ref] Mammalian initiation should be tested directly; extensive scanning rules established in a different organism cannot simply be assumed to apply.

A third mechanism is a change in the chromatin landscape or DNA supercoiling. Altered nucleosome positioning could expose cryptic gene promoters, while changed histone acetylation or chromatin remodelling could broaden the region accessible to the preinitiation complex. Map chromatin accessibility, nucleosomes and relevant histone modifications before and soon after X treatment. Compare naked and nucleosomal DNA templates carrying the same core promoter; mutate the proposed chromatin remodelling factor or use acute depletion to test whether it is required. For a proposed topoisomerase effect, compare relaxed and supercoiled templates and measure DNA supercoiling directly. Occupancy changes that follow initiation changes can be consequences, so temporal order matters.

A fourth route is indirect alteration of factor supply or activity: X might change nucleoside triphosphate pools, phosphorylation of initiation machinery, or the abundance of a limiting transcription factor. Measure candidate metabolites and protein modifications, test rapid versus delayed onset, and restore the proposed limiting input. Altered promoter-proximal pausing can change the recovery of nascent products without moving the original start; compare initiation-specific maps with downstream engaged-RNA polymerase II profiles. A change that disappears after controlling RNA lifetime or pausing is not evidence for loss of start-site selection.

Finally, identify the direct molecular target through binding or engagement assays and a resistant mutant that retains normal baseline function. Require the resistant version to rescue the start-position phenotype at an X concentration that affects the normal version; overexpression rescue alone can reflect sequestration of the compound. An acute genetic perturbation should phenocopy X, and purified biochemical assays should reproduce the relevant effect. Convergent evidence from nascent starts, controlled templates and target-specific rescue distinguishes direct selection defects from secondary changes in gene expression.

Germ plasm inheritance places germline-promoting material into selected biological cells; induction establishes germline identity through signalling to competent biological cells. Both must protect the future germline from inappropriate somatic differentiation. They differ in how that programme begins and in how broadly early transcription is repressed. primordial germ cells are precursors of future gametes, not simply biological cells expressing one widely shared germ-cell marker.

In Drosophila melanogaster, maternal oskar messenger RNA is transported to the posterior oocyte and locally translated. Oskar organises germ plasm containing RNA and proteins, including Vasa, Tudor and Nanos. Posterior cell nuclei encounter this specialised cytoplasm and cellularise as pole cells. Necessity and positional sufficiency are distinguishable: loss of Oskar disrupts assembly, while experimentally mislocalised oskar messenger RNA can induce anterior pole cells. The latter result shows that the organising material can redirect where the programme begins; it does not mean that Oskar acts without the other cellular components.^[ref]

Assembly and inheritance also should not be equated with one universal granule mechanism. A germ plasm is a spatially organised collection of functional components; the visible granule and the whole regulatory activity are not necessarily identical. Test assembly by tracking recruitment order, deleting candidate organisers and rescuing them at physiological levels. Test specification separately by permanent lineage tracing and later contribution to the gonad and, where experimentally feasible, functional gametes. Disrupting a visible aggregate without abolishing the relevant biochemical activity is not evidence that all germline specification has failed.

In fly pole cells, a direct route to transcriptional quiescence is the small Pgc protein, translated from inherited germ-plasm RNA. It binds P-TEFb, a protein kinase complex needed for productive RNA polymerase II elongation, and prevents its normal recruitment to transcriptional sites. Reduced phosphorylation of the polymerase's C-terminal domain at serine 2 accompanies repression. Loss, ectopic expression, physical interaction and recruitment assays connect Pgc protein to this mechanism rather than merely correlating a silent biological cell with a granule.^[ref]

The nematode Caenorhabditis elegans illustrates another inherited route. Maternal PIE-1 segregates into the germline blastomeres and inhibits the somatic transcription programme. A repression domain with similarity to the RNA polymerase II C-terminal repeat provided a mechanistic link to the transcriptional apparatus; mutations that damage repression also weaken in-embryo rescue. Thus distinct inherited repressors can converge on productive RNA polymerase II activity. It is unnecessary to claim that PIE-1 and Pgc protein are the same molecule or that every inherited germline component acts by this mechanism.^[ref]

In the house mouse, primordial germ cells are induced from competent postimplantation epiblast rather than assigned by an already localised maternal germ plasm. BMP4 from extraembryonic biological tissues supplies an essential inductive input. BMP4 null embryos lack primordial germ cells, and chimera analysis identified an extraembryonic source requirement; fewer founders in heterozygotes showed a dosage-sensitive effect on establishment rather than simply later expansion.^[ref] Necessity of this signal does not imply that every exposed epiblast biological cell becomes germline: competence, position and competing inputs constrain the response.

The induced programme uses BLIMP1, PRDM14 and TFAP2C to repress somatic regulatory networks and establish germline identity and epigenetic reprogramming. BLIMP1 binds and represses somatic and proliferation-associated targets, while the factors also activate germline-associated programmes. This is the crucial contrast in interpreting quiescence: an induced germline must transcribe its specification programme, so selective repression of somatic genes is not equivalent to a universal shutdown of transcription. Chromatin and DNA methylation are subsequently remodelled; a hypomethylated state by itself is not evidence that the genome is transcriptionally inactive.^[ref]

Induction also differs among mammals. Human primordial germ cell-like cells require SOX17 as an important upstream specifier, with BLIMP1 helping suppress alternative somatic programmes. This comes from experimentally induced biological cells compared with available germ-cell references; it should not be presented as direct observation of every event in an intact human embryo. It demonstrates why the exact mouse hierarchy cannot simply be renamed human.^[ref]

For either mode, measure nascent RNA incorporation together with serine-2-phosphorylated RNA polymerase II, total polymerase and multiple somatic and germline transcripts. Maternal messenger RNA persistence makes total RNA abundance an unreliable measure of current synthesis. Include somatic biological cells in the same embryo as positive controls, a validated transcription-inhibited sample as a low-signal control, and viability measurements. Timed perturbation after specification distinguishes a requirement for establishing identity from one for maintaining quiescence. Rescue should recover appropriate molecular identity and later lineage function, not merely lower a staining signal. These experiments would reveal the shared aim of suppressing inappropriate differentiation while preserving the different transcriptional requirements of inheritance and induction.

Positive transcription elongation factor b, a kinase complex promoting productive RNA polymerase II elongation, including phosphorylation of the polymerase C-terminal domain.

A general transcription factor contributing to assembly and positioning of RNA polymerase II in the preinitiation complex.

A general transcription factor complex containing TATA-binding protein and associated subunits, involved in recognition and assembly at many RNA polymerase II core promoters.

A general transcription factor complex containing activities involved in promoter opening and regulation of RNA polymerase II; some components also function in DNA repair.

A DNA translocase component of TFIIH involved in opening RNA polymerase II gene promoters. It is a molecular target of triptolide.^[ref]